Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Cormorant Asset Management, Llc


  • Other at Turning Point Therapeutics Inc. (TPTX), 2019-08-12
  • Large Shareholder at Axonics Modulation Technologies Inc. (AXNX), 2018-11-02
  • Large Shareholder at Constellation Pharmaceuticals Inc (CNST), 2018-07-20
  • Large Shareholder at Kezar Life Sciences Inc. (KZR), 2018-06-27
  • Large Shareholder at Kiniksa Pharmaceuticals Ltd. (KNSA), 2018-05-31
  • Large Shareholder at Proteostasis Therapeutics Inc. (PTI), 2017-12-18
  • Large Shareholder at Apellis Pharmaceuticals Inc. (APLS), 2017-11-14
  • Large Shareholder at Clearside Biomedical Inc. (CLSD), 2016-06-13
  • Large Shareholder at Cellectar Biosciences Inc. (CLRB), 2014-09-05
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
TPTX $18.00 400,000 Large Shareholder 3,099,099 2019-04-22 Filing
AXNX $15.00 133,333 Large Shareholder 1,285,827 2018-10-31 Filing
KZR $15.00 250,000 Large Shareholder 1,572,909 2018-06-25 Filing
KNSA $18.00 69,444 Large Shareholder 900,443 2018-05-29 Filing
APLS $14.00 1,071,428 Large Shareholder 3,473,925 2017-11-13 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
PTI $4.88 504,027 Large Shareholder 3,300,000 2017-12-14 Filing